Page last updated: 2024-11-01

nitrendipine and Osteogenic Sarcoma

nitrendipine has been researched along with Osteogenic Sarcoma in 1 studies

Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"This hypothesis was tested in the osteogenic sarcoma cell line UMR 106-01."1.28Parathyroid hormone-related peptide transiently increases cytosolic calcium in osteoblast-like cells: comparison with parathyroid hormone. ( Avioli, LV; Civitelli, R; Fausto, A; Gunsten, SL; Hruska, KA; Martin, TJ, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Civitelli, R1
Martin, TJ1
Fausto, A1
Gunsten, SL1
Hruska, KA1
Avioli, LV1

Other Studies

1 other study available for nitrendipine and Osteogenic Sarcoma

ArticleYear
Parathyroid hormone-related peptide transiently increases cytosolic calcium in osteoblast-like cells: comparison with parathyroid hormone.
    Endocrinology, 1989, Volume: 125, Issue:3

    Topics: Animals; Calcium; Cell Line; Cytosol; Diltiazem; Egtazic Acid; Fluorescent Dyes; Indoles; Kinetics;

1989